EUVIMED · CrossrefZeitschrift
Cancer Pathogenesis and Therapy
ISSN 2949-7132 · Elsevier BV
Neueste Artikel
From “undruggable” to tractable: Therapeutic advances targeting Kristen rat sarcoma viral homolog glycine to cysteine mutation at codon 12 (KRAS G12C)-mutant cancers and emerging resistance mechanisms
Magnesium isoglycyrrhizinate remodels the inflammatory tumor microenvironment in gastric cancer through inhibition of the phospholipase A2 (PLA2)/nuclear factor κB (NF-κB) signaling axis
Efficacy of homoharringtonine (HHT)-based induction regimen in acute myeloid leukemia (AML) with double-mutated CCAAT/enhancer-binding protein alpha (CEBPA): A prospective multicenter, single-arm phase II trial
CAR-NK cell therapy for hepatocellular carcinoma and other liver diseases: Current evidence and future perspectives
Perspective Mechanisms and Intervention Strategies of T Cell Exhaustion in Chimeric Antigen Receptor T-cell (CAR-T) Therapy
Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions
Bridging the Diagnostic Gap in TP53-Mutated Myeloid Neoplasms: From Classification Discrepancies to a Practical cnLOH-Inclusive Diagnostic Framework
DKK1-CKAP4 axis functions as an immunometabolic checkpoint linking tumor-intrinsic signaling with immune suppression
Safety and efficacy of JWATM204, a novel glypican-3 (GPC3)-targeted chimeric antigen receptor (CAR) T-cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study
Rare internal malignancies in xeroderma pigmentosum: A report of two cases from Tunisia and analysis of driver mutations
Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance
Methionine restriction for cancer therapy: A comprehensive review of mechanisms and clinical applications
Chemoresistance: The hidden barrier in cancer treatment
Clotrimazole as a new frontier: Drug repurposing and its efficacy in cancer therapy
Emerging risk factors and the role of gut microbiota in immunomodulation and therapeutic implications in colorectal cancer
Emerging strategies in neoadjuvant therapy for non-small cell lung cancer: Progress and future directions
Inflammatory cytokines and specific factors influencing lung cancer progression
Volatile organic compounds in exhaled breath: Applications in cancer diagnosis and predicting treatment efficacy
Biomarkers, isolation methods, and therapeutic implications of breast cancer stem cells
Phytoconstituents as emerging therapeutics for breast cancer: Mechanistic insights and clinical implications
Role of Candida albicans in chronic inflammation and the development of oral squamous cell carcinoma
Advances in nanoparticle-mediated cancer therapeutics: Current research and future perspectives
Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy
Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC)
New advances in lung cancer treatment: Efficacy, safety, and future research directions
Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8+ T cell anti-tumor immunity
Cardiotoxicity in platinum-based chemotherapy: Mechanisms, manifestations, and management
Overview of skin cancer types and prevalence rates across continents
Co-culture models for investigating cellular crosstalk in the glioma microenvironment
Intraoperative glioblastoma surgery-current challenges and clinical trials: An update
EUVIMED